ADMP stock forecast
Our latest prediction for Adamis Pharmaceuticals Corp.'s stock price was made on the Nov. 18, 2019 when the stock price was at 0.87$.
In the short term (2weeks), ADMP's stock price should outperform the market by 0.54%. During that period the price should oscillate between -10.45% and +18.56%.
In the medium term (3months), ADMP's stock price should outperform the market by 9.50%. During that period the price should oscillate between -21.93% and +59.73%.Get email alerts
About Adamis Pharmaceuticals Corp.
Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.
At the moment the company generates 21M USD in revenues.
On its last earning announcement, the company reported a loss of -0.75$ per share.
The book value per share is 0.54$
Three months stock forecastNov. 18, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|